News
PRE
22.97
+0.17%
0.04
Craig-Hallum Remains a Buy on Prenetics Group (PRE)
TipRanks · 4d ago
Weekly Report: what happened at PRE last week (0914-0918)?
Weekly Report · 5d ago
Prenetics Global Price Target Announced at $40.00/Share by Craig-Hallum
Dow Jones · 09/17 14:46
Craig-Hallum Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $40
Benzinga · 09/17 14:36
Craig-Hallum bullish on Prenetics, initiates with a Buy
TipRanks · 09/17 12:55
Prenetics initiated with a Buy at Craig-Hallum
TipRanks · 09/17 11:15
Prenetics management to meet with Oppenheimer
TipRanks · 09/14 17:35
Weekly Report: what happened at PRE last week (0907-0911)?
Weekly Report · 09/14 10:14
Weekly Report: what happened at PRE last week (0831-0904)?
Weekly Report · 09/07 10:08
Weekly Report: what happened at PRE last week (0824-0828)?
Weekly Report · 08/31 10:14
Prenetics Global Price Target Announced at $37.00/Share by B. Riley Securities
Dow Jones · 08/27 17:53
Prenetics Global Initiated at Buy by B. Riley Securities
Dow Jones · 08/27 17:53
B. Riley Securities Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $37
Benzinga · 08/27 17:43
Prenetics initiated with a Buy at B. Riley
TipRanks · 08/27 09:05
CFO’s Bold Move Signals Growing Confidence in Prenetics Group
TipRanks · 08/27 02:08
Prenetics Leaders Boost $3.75 Million Insider Stakes After Strong Q2 and IM8 Surge
TipRanks · 08/26 13:16
Prenetics Global CEO and CFO purchase $1M of shares in open market
Seeking Alpha · 08/26 12:57
Prenetics Global CEO Danny Yeung And CFO Brian Rosin Acquire Total Of $1M Worth Of Shares In Open Market Purchases
Benzinga · 08/26 12:40
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
Barchart · 08/26 07:38
Prenetics Group Limited Earnings Call Signals High-Growth Push
TipRanks · 08/25 00:04
More
Webull provides a variety of real-time PRE stock news. You can receive the latest news about Prenetics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRE
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.